Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01146704 · ClinicalTrials.gov registry record · NA
Gastrointestinal Hormonal Regulation of Obesity
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT01146704: Completed NA study, sponsored by VA Office of Research and Development.
NCT01146704 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01146704, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The objective of this study is to test and determine whether a high protein diet is efficacious, safe and beneficial to curtail food intake and body weight in obese adult human patients and to establish whether neurohormonal mechanisms of a high protein diet induce an early signal of fullness or satiety in a relevant experimental model, focusing on activation of gastric vagal afferents.
Primary Outcome
The primary objective is to compare weight loss between each of the two diets, a high-protein diet versus a standard diet.
Interventions
- DIETARY_SUPPLEMENT Protein powder supplement, standard dosage based on 0.5 gram protein per pound of subject's lean body mass
- DIETARY_SUPPLEMENT Protein powder supplement, High Level Protein, based on 1 gram of protein per pound of lean body mass: 25% protein and 45% carbohydrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2010-09-01 |
| Est. Completion | 2019-02-27 |
| Phase | NA |
What the finished NCT01146704 record still lists
NCT01146704 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Protein powder supplement, standard dosage based on 0.5 gram protein per pound of subject's lean body mass is the first listed.
NCT01146704 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01146704 about?
NCT01146704 is a clinical study titled "Gastrointestinal Hormonal Regulation of Obesity". The objective of this study is to test and determine whether a high protein diet is efficacious, safe and beneficial to curtail food intake and body weight in obese adult human patients and to establish whether neurohormonal mechanisms of a high protein diet induce an early signal of fullness or sat...
What is the current status of trial NCT01146704?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2010-09-01. Estimated completion is 2019-02-27.
What interventions are being tested in trial NCT01146704?
The interventions under investigation include: Protein powder supplement, standard dosage based on 0.5 gram protein per pound of subject's lean body mass (DIETARY_SUPPLEMENT), Protein powder supplement, High Level Protein, based on 1 gram of protein per pound of lean body mass: 25% protein and 45% carbohydrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01146704?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01146704's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI